Get 20% Free Customization In This Report

Buy this report from - $3456

Clinical Laboratory Tests Market by Product (Blood Count, HGB/HCT Testing, Basic Metabolic Panel Testing, BUN Creatinine Testing, Electrolytes Testing, Hba1c Testing, Comprehensive Metabolic Panel Testing, Liver Panel Testing, Renal Panel Testing, and Lipid Panel Testing), Test (Routine and Specialty Tests), Department (Parasitology, Virology, Hematology, Toxicology, Immunology/Serology, Histopathology, and Urinalysis), and Service Provider (Hospital-based Laboratories, Stand-alone Laboratories, and Clinics-based Laboratories) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Healthcare	LI_183184	Pages: NA	Jul 2018 \| 773 Views
Author's : NA	Tables: NA	Charts: NA	Formats*:

Clinical laboratory tests is a group of medical tests carried out in a laboratory equipped with all aspects of laboratory medicine and instruments. These tests are performed on clinical specimen to obtain information about the health of patients, and diagnosis & treatment of their respective condition.

The global clinical laboratory tests market is driven by high prevalence of diseases, such as cardiovascular and neurological diseases, rise in geriatric population, development of technologically advanced products, such as biochips and microarrays, and surge in healthcare expenditure. Moreover, preference for preventive medicine, shorter hospital stay, and high demand for integrated analytical systems fuel the market growth. However, control of the FDA over laboratory-based tests delays the launch of new products and lack of skilled professionals in clinics based in emerging economies hamper this growth. Moreover, introduction and implementation of database management tools and solutions with reduced errors, increased efficiency, and satisfactory services are expected to present opportunities for the market growth in the near future.

The clinical laboratory tests market is segmented on the basis of product, test, department, end user, and region. On the basis of product, it is divided into complete blood count, HGB/HCT testing, basic metabolic panel testing, BUN creatinine testing, electrolytes testing, HbA1c testing, comprehensive metabolic panel testing, liver panel testing, renal panel testing, and lipid panel testing. Liver panel testing is further subsegmented into hepatitis, bile duct obstruction, liver cirrhosis, liver cancer, bone disease, autoimmune disorders, and others. On the basis of test, market is bifurcated into routine and specialty tests. Based on department, it is classified into parasitology, virology, hematology, toxicology, immunology/serology, histopathology, urinalysis, and others (microbiology, genetics, cytopathology, cytogenetics, and others). Based on service provider, the market is categorized into hospital-based laboratories, stand-alone laboratories, and clinic-based laboratories. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players operating in this market include Abbott Laboratories, Inc., Quest Diagnostics, Inc., Sonic Healthcare Ltd., Siemens Healthineers, OPKO Health, Inc., Laboratory Corporation of America, LLC, Charles River Laboratories International, Inc., NeoGenomics Laboratories Inc., Genoptix, Inc., and Bioscientia Institut fr Medizinische Diagnostik GmbH.

Key Benefits

Market analysis for the global clinical laboratory test market is provided with region-specific assessments and competition analysis on the global and regional scale.
The report provides an extensive information about the current and upcoming trends in the market through 20162023, which help to determine the potential growth opportunities.
Key drivers and restraints impacting the market are listed in the report.
Identification of factors instrumental in changing the market scenario, prospective opportunities, and key companies that can influence this market is presented.
A wide-ranging knowledge and insights about major players in this industry and the key strategies adopted by them to sustain and grow are analyzed.

Clinical Laboratory Tests Market Key Segments:

By Product

Complete Blood Count
HGB/HCT Testing
Basic Metabolic Panel Testing
BUN Creatinine Testing
Electrolytes Testing
HbA1c Testing
Comprehensive Metabolic Panel Testing
Liver Panel Testing
- Hepatitis
- Bile Duct Obstruction
- Liver Cirrhosis
- Liver Cancer
- Bone Disease
- Autoimmune Disorders
- Others
Renal Panel Testing
Lipid Panel Testing

By Test

Routine
Specialty

By Department

Parasitology
Virology
Hematology
Toxicology
Immunology/Serology
Histopathology
Urinalysis
Others (Microbiology, Clinical Biochemistry, Cytopathology, Genetics, and Surgical Pathology)

By Service Provider

Hospital-based Laboratories
Stand-alone Laboratories
Clinic-based Laboratories

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS

3.4.1. MARKET DYNAMICS
3.4.2. Drivers
3.4.3. Restraints
3.4.4. Opportunities

Chapter: 4 CLINICAL LABORATORY TESTS MARKET, BY PRODUCT TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. COMPLETE BLOOD COUNT

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. HGB/HCT TESTING

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. BASIC METABOLIC PANEL TESTING

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

4.5. BUN CREATININE TESTING

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast

4.6. ELECTROLYTES TESTING

4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast

4.7. HBA1C TESTING

4.7.1. Key market trends
4.7.2. Growth factors and opportunities
4.7.3. Market size and forecast

4.8. COMPREHENSIVE METABOLIC PANEL TESTING

4.8.1. Key market trends
4.8.2. Growth factors and opportunities
4.8.3. Market size and forecast

4.9. LIVER PANEL TESTING

4.9.1. Key market trends
4.9.2. Growth factors and opportunities
4.9.3. Market size and forecast

4.9.3.1. Hepatitis market size and forecast
4.9.3.2. Bile Duct Obstruction market size and forecast
4.9.3.3. Liver Cirrhosis market size and forecast
4.9.3.4. Liver Cancer market size and forecast
4.9.3.5. Bone disease market size and forecast
4.9.3.6. Autoimmune Disorders market size and forecast
4.9.3.7. Others market size and forecast

4.10. RENAL PANEL TESTING

4.10.1. Key market trends
4.10.2. Growth factors and opportunities
4.10.3. Market size and forecast

4.11. LIPID PANEL TESTING

4.11.1. Key market trends
4.11.2. Growth factors and opportunities
4.11.3. Market size and forecast

Chapter: 5 CLINICAL LABORATORY TESTS MARKET, BY DEPARTMENTS

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. PARASITOLOGY

5.2.1. Market size and forecast

5.3. VIROLOGY

5.3.1. Market size and forecast

5.4. HEMATOLOGY

5.4.1. Market size and forecast

5.5. TOXICOLOGY

5.5.1. Market size and forecast

5.6. HISTOPATHOLOGY

5.6.1. Market size and forecast

5.7. URINALYSIS

5.7.1. Market size and forecast

5.8. OTHERS

5.8.1. Market size and forecast

Chapter: 6 CLINICAL LABORATORY TESTS MARKET, BY SERVICE PROVIDER

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. HOSPITAL-BASED LABORATORIES

6.2.1. Market size and forecast

6.3. STAND-ALONE LABORATORIES

6.3.1. Market size and forecast

6.4. CLINIC-BASED LABORATORIES

6.4.1. Market size and forecast

Chapter: 7 CLINICAL LABORATORY TESTS MARKET, BY REGION

7.1. OVERVIEW
7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast

7.2.3.1. U.S. market size and forecast
7.2.3.2. Canada market size and forecast
7.2.3.3. Mexico market size and forecast

7.2.4. North America clinical laboratory tests market by product type
7.2.5. North America clinical laboratory tests market by department
7.2.6. North America clinical laboratory tests market by service provider

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast

7.3.3.1. Germany market size and forecast
7.3.3.2. France market size and forecast
7.3.3.3. UK market size and forecast
7.3.3.4. Italy market size and forecast
7.3.3.5. Spain market size and forecast
7.3.3.6. Rest of Europe market size and forecast

7.3.4. Europe clinical laboratory tests market by product type
7.3.5. Europe clinical laboratory tests market by department
7.3.6. Europe clinical laboratory tests market by service provider

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast

7.4.3.1. Japan market size and forecast
7.4.3.2. China market size and forecast
7.4.3.3. Australia market size and forecast
7.4.3.4. India market size and forecast
7.4.3.5. South Korea market size and forecast
7.4.3.6. Taiwan market size and forecast
7.4.3.7. Rest of Asia-Pacific market size and forecast

7.4.4. Asia-Pacific clinical laboratory tests market by product type
7.4.5. Asia-Pacific clinical laboratory tests market by department
7.4.6. Asia-Pacific clinical laboratory tests market by service provider

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast

7.5.3.1. Brazil market size and forecast
7.5.3.2. Turkey market size and forecast
7.5.3.3. Saudi Arabia market size and forecast
7.5.3.4. South Africa market size and forecast
7.5.3.5. Rest of LAMEA market size and forecast

7.5.4. LAMEA clinical laboratory tests market by product type
7.5.5. LAMEA clinical laboratory tests market by department
7.5.6. LAMEA clinical laboratory tests market by service provider

Chapter: 8 COMPANY PROFILES

8.1. ABBOTT LABORATORIES

8.1.1. Operating business segments
8.1.2. Business performance
8.1.3. Key strategic moves and developments

8.2. QUEST DIAGNOSTICS, INC.

8.2.1. Operating business segments
8.2.2. Business performance
8.2.3. Key strategic moves and developments

8.3. SONIC HEALTHCARE LTD.

8.3.1. Operating business segments
8.3.2. Business performance
8.3.3. Key strategic moves and developments

8.4. SIEMENS HEALTHINEERS

8.4.1. Operating business segments
8.4.2. Business performance
8.4.3. Key strategic moves and developments

8.5. OPKO HEALTH, INC.

8.5.1. Operating business segments
8.5.2. Business performance
8.5.3. Key strategic moves and developments

8.6. LABORATORY CORPORATION OF AMERICA, LLC

8.6.1. Operating business segments
8.6.2. Business performance
8.6.3. Key strategic moves and developments

8.7. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

8.7.1. Operating business segments
8.7.2. Business performance
8.7.3. Key strategic moves and developments

8.8. NEOGENOMICS LABORATORIES INC.

8.8.1. Operating business segments
8.8.2. Business performance
8.8.3. Key strategic moves and developments

8.9. GENOPTIX, INC.

8.9.1. Operating business segments
8.9.2. Business performance
8.9.3. Key strategic moves and developments

8.10. BIOSCIENTIA INSTITUT FÜR MEDIZINISCHE DIAGNOSTIK GMBH

8.10.1. Operating business segments
8.10.2. Business performance
8.10.3. Key strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Shopping Cart is Empty..

Your Shopping Cart Is Empty